ArticleThe American journal of case reports2026
Coexistence of Neurofibromatosis Type 1 and Marfan Syndrome in a 13-Year-Old Boy: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Neurofibromatosis type 1 (NF1) and Marfan syndrome (MFS) are genetically determined systemic disorders. Their simultaneous occurrence is exceptionally rare, with only a few cases reported in the literature. CASE REPORT A 13-year-old boy was admitted to a cardiology clinic due to mitral and tricuspid valve prolapse. He was tall, with severe scoliosis and distinctive dysmorphic features typical of MFS. More than 20 cafe-au-lait spots, characteristic of NF1, were present on his skin. The family history included NF1 in his twin brother, mother, maternal uncle, and maternal grandmother. The maternal uncle also exhibited phenotypic features of MFS and died at a young age from a suspected ruptured intracranial aneurysm. Genetic testing in our patient revealed an NF1 mutation, as well as a 16p13.11 microduplication that could explain his developmental delay and speech difficulties. The diagnosis of MFS was based on characteristic dysmorphic features and the presence of aortic root dilation, despite negative findings concerning the fibrillin-1 (FBN1) mutation typically associated with MFS. CONCLUSIONS A thorough assessment of physical features is essential to detect atypical phenotypes and recognize potential coexistence of multiple genetic syndromes. This case highlights the clinical importance of systematic cardiac evaluation, given that cardiac abnormalities typical of MFS may be critical for its recognition. Reporting such an unusual coexistence of NF1 and MFS underscores the need for multidisciplinary care to improve long-term outcomes in patients with overlapping genetic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.